99 related articles for article (PubMed ID: 19815998)
1. Risperidone treatment increases CB1 receptor binding in rat brain.
Secher A; Husum H; Holst B; Egerod KL; Mellerup E
Neuroendocrinology; 2010; 91(2):155-68. PubMed ID: 19815998
[TBL] [Abstract][Full Text] [Related]
2. Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Andersson M; Terasmaa A; Fuxe K; Strömberg I
J Neurosci Res; 2005 Oct; 82(2):264-72. PubMed ID: 16175569
[TBL] [Abstract][Full Text] [Related]
3. Effects of risperidone treatment on the expression of hypothalamic neuropeptide in appetite regulation in Wistar rats.
Kursungoz C; Ak M; Yanik T
Brain Res; 2015 Jan; 1596():146-55. PubMed ID: 25449893
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expressions of mRNA for neuropeptide Y and interleukin 1 beta in hypothalamic arcuate nuclei during adjuvant arthritis-induced anorexia in Lewis rats.
Stofkova A; Haluzik M; Zelezna B; Kiss A; Skurlova M; Lacinova Z; Jurcovicova J
Neuroimmunomodulation; 2009; 16(6):377-84. PubMed ID: 19609086
[TBL] [Abstract][Full Text] [Related]
5. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis.
Marcellino D; Carriba P; Filip M; Borgkvist A; Frankowska M; Bellido I; Tanganelli S; Müller CE; Fisone G; Lluis C; Agnati LF; Franco R; Fuxe K
Neuropharmacology; 2008 Apr; 54(5):815-23. PubMed ID: 18262573
[TBL] [Abstract][Full Text] [Related]
7. Effects of sucrose, glucose and fructose on peripheral and central appetite signals.
Lindqvist A; Baelemans A; Erlanson-Albertsson C
Regul Pept; 2008 Oct; 150(1-3):26-32. PubMed ID: 18627777
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
9. The role of the cannabinoid type 1 receptor and down-stream cAMP/DARPP-32 signal in the nucleus accumbens of methamphetamine-sensitized rats.
Chiang YC; Chen JC
J Neurochem; 2007 Dec; 103(6):2505-17. PubMed ID: 17953657
[TBL] [Abstract][Full Text] [Related]
10. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
Weston-Green K; Huang XF; Deng C
PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
[TBL] [Abstract][Full Text] [Related]
12. Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways.
Lian J; De Santis M; He M; Deng C
Pharmacol Res; 2015; 95-96():20-6. PubMed ID: 25782398
[TBL] [Abstract][Full Text] [Related]
13. Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
Fell MJ; Neill JC; Marshall KM
Eur Neuropsychopharmacol; 2004 Oct; 14(5):385-92. PubMed ID: 15336300
[TBL] [Abstract][Full Text] [Related]
14. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
Hertel P; Nomikos GG; Svensson TH
Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
[TBL] [Abstract][Full Text] [Related]
16. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
[TBL] [Abstract][Full Text] [Related]
17. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat.
Mijnster MJ; Schotte A; Docter GJ; Voorn P
Synapse; 1998 Apr; 28(4):302-12. PubMed ID: 9517839
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
20. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]